CDKN1A and hepatocellular carcinoma: The key sphingolipid metabolite ceramide, which increases in response to many stressors, has been reported to mediate growth arrest in a p21-dependent manner, promote G1 arrest in hepatoma cells, and to drive p21-dependent G2 arrest in rhabdomyosarcoma cells (30, 31, 32).